These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tigecycline. Bhattacharya M; Parakh A; Narang M J Postgrad Med; 2009; 55(1):65-8. PubMed ID: 19242083 [TBL] [Abstract][Full Text] [Related]
6. Tigecycline for the treatment of infections due to resistant Gram-positive organisms. Squires RA; Postier RG Expert Opin Investig Drugs; 2006 Feb; 15(2):155-62. PubMed ID: 16433594 [TBL] [Abstract][Full Text] [Related]
7. Tigecycline: a new glycylcycline for treatment of serious infections. Noskin GA Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS; Jones RN; Dowzicky MJ; Fritsche TR Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [TBL] [Abstract][Full Text] [Related]
9. Tigecycline: first of a new class of antimicrobial agents. Rose WE; Rybak MJ Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [TBL] [Abstract][Full Text] [Related]
10. The glycylcyclines: a comparative review with the tetracyclines. Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ Drugs; 2004; 64(1):63-88. PubMed ID: 14723559 [TBL] [Abstract][Full Text] [Related]
11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E; J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704 [TBL] [Abstract][Full Text] [Related]
12. New antibiotic agents: problems and prospects. Weber DJ; Rutala WA Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500 [TBL] [Abstract][Full Text] [Related]
14. Overview of tigecycline and its role in the era of antibiotic resistance. Rossi F; Andreazzi D Braz J Infect Dis; 2006 Jun; 10(3):203-16. PubMed ID: 17568854 [TBL] [Abstract][Full Text] [Related]
15. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Hawkey P; Finch R Clin Microbiol Infect; 2007 Apr; 13(4):354-62. PubMed ID: 17359318 [TBL] [Abstract][Full Text] [Related]
16. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? Fraise AP J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253 [TBL] [Abstract][Full Text] [Related]